Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Johnson, Matthew P ^a   Brennecke, Shaun P ^b   East, Christine E ^b   Göring, Harald H H ^a   Kent, Jack W ^a   Dyer, Thomas D ^a   Said, Joanne M ^b   Roten, Linda T ^c   Iversen, Ann Charlotte ^c   Abraham, Lawrence J ^d   Heinonen, Seppo ^e   Kajantie, Eero ^f,g   Kere, Juha ^h,i,j   Kivinen, Katja ^k   Pouta, Anneli ^f   Laivuori, Hannele ^j,l   Austgulen, Rigmor ^c   Blangero, John ^a   Moses, Eric K ^a,d  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^j UNIVERSITY OF HELSINKI   (Finland)

^k WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^l UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN; INHIBIN B; MESSENGER RNA; TRANSCRIPTION FACTOR; INHBB PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; AUSTRALIAN; BINDING SITE; CAUCASIAN; CENTROMERE; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 2Q; CONTROLLED STUDY; DECIDUA; DNA SEQUENCE; EPB41L5 GENE; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREECLAMPSIA; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; TRANSCRIPTION INITIATION SITE; AUSTRALIA; BIOLOGY; CHROMOSOME 2; COHORT ANALYSIS; FINLAND; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; METABOLISM; NORWAY; PREGNANCY; REPRODUCIBILITY;

AUSTRALIA; CHROMOSOMES, HUMAN, PAIR 2; COHORT STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; FINLAND; GENE EXPRESSION REGULATION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHIBIN-BETA SUBUNITS; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84863399988     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033666     Document Type: Article

References (67)

1. Witlin AG, Sibai BM, (1997) Hypertension in pregnancy: Current concepts of preeclampsia. Annu Rev Med 48: 115-27.
2. Roberts JM, Pearson G, Cutler J, Lindheimer M, (2003) Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41 (3): 437-45.
3. Roberts JM, Gammill HS, (2005) Preeclampsia: Recent insights. Hypertension 46 (6): 1243-9.
4. Duley L, (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33 (3): 130-137.
5. Tang LC, Kwok AC, Wong AY, Lee YY, Sun KO, et al. (1997) Critical care in obstetrical patients: An eight-year review. Chin Med J (Engl) 110 (12): 936-41.
6. Goldenberg RL, Rouse DJ, (1998) Prevention of premature birth. N Engl J Med 339 (5): 313-20.
7. Basso O, Rasmussen S, Weinberg CR, Wilcox AJ, Irgens LM, et al. (2006) Trends in fetal and infant survival following preeclampsia. Jama 296 (11): 1357-62.
8. Roberts JM, Hubel CA, (2009) The two stage model of preeclampsia: Variations on the theme. Placenta 30 (Suppl A): S32-7.
9. Redman CW, Sargent IL, (2009) Placental stress and pre-eclampsia: A revised view. Placenta 30 (Suppl A): S38-42.
10. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (5): 649-658.
11. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (1): S1-S22.
12. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, et al. (1989) Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 161 (5): 1200-1204.
13. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278 (15): 12605-12608.
14. Rodie VA, Freeman DJ, Sattar N, Greer IA, (2004) Pre-eclampsia and cardiovascular disease: Metabolic syndrome of pregnancy? Atherosclerosis 175 (2): 189-202.
15. Irgens HU, Reisaeter L, Irgens LM, Lie RT, (2001) Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. Bmj 323 (7323): 1213-7.
16. Roberts JM, Hubel CA, (2010) Pregnancy: A screening test for later life cardiovascular disease. Womens Health Issues 20 (5): 304-307.
17. Roberts JM, Cooper DW, (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357 (9249): 53-6.
18. Sattar N, Greer IA, (2002) Pregnancy complications and maternal cardiovascular risk: Opportunities for intervention and screening? BMJ 325 (7356): 157-160.
19. Johansson A, Curran JE, Johnson MP, Freed KA, Fenstad MH, et al. (2011) Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet 19 (7): 796-800.
20. Roten LT, Fenstad MH, Forsmo S, Johnson MP, Moses EK, et al. (2011) A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 17 (7): 439-446.
21. Williams PJ, Pipkin FB, (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25 (4): 405-417.
22. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, et al. (2000) A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67 (6): 1581-5.
23. Johnson MP, Fitzpatrick E, Dyer TD, Jowett JB, Brennecke SP, et al. (2007) Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 13 (1): 61-67.
24. Fitzpatrick E, Johnson MP, Dyer TD, Forrest S, Elliott K, et al. (2009) Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia. Mol Hum Reprod 15 (3): 195-204.
25. Roten LT, Johnson MP, Forsmo S, Fitzpatrick E, Dyer TD, et al. (2009) Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur J Hum Genet 17 (2): 250-257.
26. Johnson MP, Roten LT, Dyer TD, East CE, Forsmo S, et al. (2009) The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Hum Genet 126 (5): 655-666.
27. Fenstad MH, Johnson MP, Roten LT, Aas PA, Forsmo S, et al. (2010) Genetic and molecular functional characterization of variants within TNFSF13B, a positional candidate preeclampsia susceptibility gene on 13q. PLoS One 5 (9): e12993.
28. Zintzaras E, Santos M, (2011) Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 11 (1): 171.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 (3): 559-575.
30. Wingender E, Chen X, Hehl R, Karas H, Liebich I, et al. (2000) TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 28 (1): 316-319.
31. Chekmenev DS, Haid C, Kel AE, (2005) P-match: Transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res 33 (Web Server issue): W432-7.
32. Grabe N, (2002) AliBaba2: Context specific identification of transcription factor binding sites. In Silico Biol 2 (1): S1-15.
33. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, et al. NCI-NHGRI Working Group on Replication in Association Studies (2007) Replicating genotype-phenotype associations. Nature 447 (7145): 655-660.
34. Shriner D, Vaughan LK, Padilla MA, Tiwari HK, (2007) Problems with genome-wide association studies. Science 316 (5833): 1840-1842.
35. Williams SM, Canter JA, Crawford DC, Moore JH, Ritchie MD, et al. (2007) Problems with genome-wide association studies. Science 316 (5833): 1840-1842.
36. Greene CS, Penrod NM, Williams SM, Moore JH, (2009) Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 4 (6): e5639.
37. Moses EK, Fitzpatrick E, Freed KA, Dyer TD, Forrest S, et al. (2006) Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 12 (8): 505-512.
38. Petraglia F, Aguzzoli L, Gallinelli A, Florio P, Zonca M, et al. (1995) Hypertension in pregnancy: Changes in activin A maternal serum concentration. Placenta 16 (5): 447-54.
39. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL, (1997) Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 349 (9061): 1285-8.
40. Fraser RF 2nd, McAsey ME, Coney P, (1998) Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin. Am J Reprod Immunol 40 (1): 37-42.
41. Caniggia I, Winter J, Lye SJ, Post M, (2000) Oxygen and placental development during the first trimester: Implications for the pathophysiology of pre-eclampsia. Placenta 21 (Suppl A): S25-30.
42. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, et al. (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15 (7): 1640-5.
43. Casagrandi D, Bearfield C, Geary J, Redman CW, Muttukrishna S, (2003) Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia. Mol Hum Reprod 9 (4): 199-203.
44. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (6): 642-649.
45. Wang A, Rana S, Karumanchi SA, (2009) Preeclampsia: The role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24: 147-158.
46. Jones RL, Findlay JK, Salamonsen LA, (2006) The role of activins during decidualisation of human endometrium. Aust N Z J Obstet Gynaecol 46 (3): 245-9.
47. Khong TY, De Wolf F, Robertson WB, Brosens I, (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93 (10): 1049-1059.
48. Pijnenborg R, Vercruysse L, Hanssens M, (2006) The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 27 (9-10): 939-58.
49. Redman CW, Sargent IL, (2010) Immunology of pre-eclampsia. Am J Reprod Immunol 63 (6): 534-543.
50. Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, et al. (2003) The Nord-Trøndelag health study 1995-97 (HUNT 2): Objectives, contents, methods and participation. Norsk Epidemiologi 13 (1): 19-32.
51. Holmen J, Kjelsaas MB, Krüger Ø, Ellekjær H, Bratberg G, et al. (2004) [Attitudes to genetic epidemiology- illustrated by questions for re-consent to 61,426 participants at HUNT]. Norsk Epidemiologi 14 (1): 27-31.
52. Moses EK, Johnson MP, Tommerdal L, Forsmo S, Curran JE, et al. (2008) Genetic association of preeclampsia to the inflammatory response gene SEPS1. Am J Obstet Gynecol 198 (3): 336.e1-336.e5.
53. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K, (2000) 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 96 (2): 277-280.
54. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, et al. (2009) Blood group AB and factor V leiden as risk factors for pre-eclampsia: A population-based nested case-control study. Thromb Res 124 (2): 167-173.
55. Brown MA, Gallery EDM, Gatt SP, Leslie G, Robinson J, (1993) Management of hypertension in pregnancy: Executive summary. Med J Aust 158 (10): 700-2.
56. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, et al. (2000) The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust N Z J Obstet Gynaecol 40 (2): 133-8.
57. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, et al. (2009) Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49 (3): 242-246.
58. Fitzpatrick E, Göring HH, Liu H, Borg A, Forrest S, et al. (2004) Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum Biol 76 (6): 849-62.
59. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437 (7063): 1299-1320.
60. Frazer KA, Ballinger DG, Cox DR, Hinds DA, et al. International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (7164): 851-861.
61. Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, et al. International HapMap 3 Consortium (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467 (7311): 52-58.
62. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L, (2004) ECR browser: A tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32 (Web Server issue): W280-6.
63. Løset M, Mundal SB, Johnson MP, Fenstad MH, Freed KA, et al. (2011) A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol 204 (1): 84.e1-84.27.
64. Browning SR, Browning BL, (2007) Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81 (5): 1084-1097.
65. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2): 263-265.
66. Duggal P, Gillanders EM, Holmes TN, Bailey-Wilson JE, (2008) Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics 9: 516.
67. Fisher RA, (1922) On the interpretation of X2 from contingency tables, and the calculation of P. J R Stat Soc 85 (1): 87-94.